Quick answer: a CAPA report for an out-of-specification (OOS) pH result has five parts: correction (containment), root cause analysis, corrective action, preventive action and an effectiveness check. Markers reward a root cause that is proved with scientific evidence and traced to a system gap, never a vague “operator error”.
If your module asks you to link Deming, Crosby and Juran to ICH Q10 and then write a CAPA for a failed batch of phosphate-buffered saline (PBS), you are being asked to prove you can move from theory to a regulated record. This guide shows how to approach the CAPA half of that task, where marks are usually lost, and how the quality gurus fit in. You can read the full task on the quality gurus, ICH Q10 and CAPA report question page.
Short on time? Our Irish team can write a referenced CAPA report to your own brief. Submit your assignment for a free quote.
What a CAPA report must show in a pharma assignment
ICH Q10 treats corrective action and preventive action as a core element of the pharmaceutical quality system. It says the system should investigate problems to find root causes, with the depth of effort proportionate to the risk (European Medicines Agency, 2015, section 3.2.2). The EU GMP Guide also expects an appropriate level of root cause analysis for deviations (European Commission, 2013).
In a typical brief the batch is already on QA hold, so you start with the OOS investigation, not a blank page. The FDA guidance splits that into a laboratory phase and a full-scale phase, and warns against retesting until a passing result appears (Food and Drug Administration, 2022).
| CAPA part | Question it answers | What a strong answer includes |
|---|---|---|
| Correction | What do we do now to contain the problem? | QA hold, deviation number, checks on other batches or shared materials |
| Root cause analysis | Why did it happen? | Ishikawa or 5 Whys, several scientific hypotheses tested, one proved |
| Corrective action | How do we fix this event? | Batch disposition (reject or justified rework), record correction |
| Preventive action | How do we stop it recurring or occurring elsewhere? | SOP and template changes, automation, calibration policy |
| Effectiveness check | How will we know it worked? | Measurable criteria, such as the next 10 batches, with a closure rule |
How to run the root cause analysis for an OOS pH deviation
This is where the heaviest marks sit, so spend your word count here. Use a structured tool and then test each branch against evidence rather than just listing it.
Step 1: Draw the Ishikawa branches
Group causes under method, machine, material, measurement, environment and people. Under measurement, list calibration and temperature. Under method or material, list the phosphate salts and cleaning.
Step 2: Test the four classic scientific causes
- Calibration and Nernst slope: the theoretical slope is 59.16 mV per pH unit at 25 °C. Show that a plausible slope error near the calibration points moves a pH around 7.4 by a few hundredths, not half a unit.
- Temperature at measurement: confirm whether the meter compensated and how far the sample was from 25 °C. Phosphate buffers move only slightly with temperature.
- Monobasic to dibasic ratio: use the Henderson-Hasselbalch equation. Because pH follows the logarithm of the base-to-acid ratio, a 0.5 rise needs that ratio to grow about three-fold (100.5), which a large under-charge of the monobasic salt would cause.
- Alkaline cleaning residue: use the final-rinse results, and note that a 10 mM phosphate buffer resists small contamination.
Step 3: Choose one definitive root cause and drill down to the system
Ask “why” until you reach a process or procedure, such as a change-control gap or a weighing step with no automatic limit check. Markers penalise “the operator made a mistake” as superficial because it names a symptom. Deming argued that most problems belong to the system and are management’s responsibility, which gives you a defensible academic reason for going deeper (Deming, 2000).
Want to see a finished answer first? Browse our model answer samples for science and quality modules.
Where the quality gurus and ICH Q10 earn marks
Treat the gurus as lenses, not a separate essay. One strong sentence per idea, tied to evidence, scores better than a page of biography.
| Guru | Idea to cite | Where it connects to ICH Q10 or your CAPA |
|---|---|---|
| Deming | PDCA, system responsibility of management | Management responsibility and the improvement cycle in CAPA |
| Crosby | Conformance to requirements, prevention, price of nonconformance | Preventive actions and the cost of a rejected 1,000 L batch (Crosby, 1979) |
| Juran | Quality Trilogy, Pareto “vital few” | Planning, control and improvement, and trending causes across deviations (Juran and De Feo, 2017) |
For critical evaluation, mention that the evidence on ICH Q10’s impact is positive but limited. One benchmarking study found higher scores after the guideline but could not prove causation (VanDuyse, Fulford and Bartlett, 2021), and an earlier commentary argued that many firms had not yet transformed their quality systems (Calnan, O’Donnell and Greene, 2013).
Common mistakes that cost marks
- Naming “human error” as the root cause and stopping there.
- Listing causes without proving or ruling them out with data.
- Proposing retraining as the only preventive action.
- Reworking the batch without saying whether rework is pre-approved.
- Writing an effectiveness check with no numbers, no time frame and no closure rule.
- Using invented data that is not labelled as illustrative.
- Skipping the real guidelines, so the answer reads as opinion.
Checklist before you submit
- All five CAPA headings appear in the right order.
- At least three scientific causes are tested, and one is selected with evidence.
- The root cause points to a system or procedure gap.
- Disposition of the batch is justified against a regulatory source.
- Preventive actions have owners, deadlines and an ICH Q10 link.
- The effectiveness check has measurable criteria.
- Every claim is cited in Harvard style and only from allowed sources.
- Your word count matches the split in the brief, and your formatting follows the course rules.
What students usually worry about
Students on this type of module commonly ask how to create realistic data without breaking academic rules, how much chemistry to show in a quality module, and how to cite regulators. The answers are to label made-up findings “illustrative”, to show one or two calculations that really prove your point, and to cite the regulator’s page with an access date. To see how a finished version reads, look at the ICH Q10 CAPA report sample written for this exact scenario (for reference only, not to be submitted as your own work).
Need support with a pharmaceutical quality assignment?
This guide was reviewed by Aoife Ryan, who holds a Ph.D. in Environmental Science from the University of Limerick and is proficient in Harvard referencing. If you want a structured written report, see our report writing services. You can read how we work on the about us page, and see a different brief on the ICH Q10 essay question page.
FAQs
What is a CAPA report in pharmaceutical manufacturing?
A CAPA report is a formal record of how a deviation was contained, investigated and prevented from recurring. It covers correction, root cause, corrective action, preventive action and effectiveness checks, in line with ICH Q10 section 3.2.2.
How many root causes should I choose?
Choose one definitive root cause, supported by evidence, after testing at least three scientific alternatives. Listing contributing factors is acceptable, but the report should state which cause is proved.
Why is “human error” penalised as a root cause?
It describes who acted, not why the system allowed the failure. Regulators expect an appropriate level of root cause analysis, so ask what process, record or control made the error possible.
Can I rework a PBS batch that is out of specification for pH?
Only if rework is pre-approved in a controlled procedure. Otherwise reject the batch and explain why, because a confirmed OOS result means the batch does not meet its specification (Food and Drug Administration, 2022).
What counts as a good effectiveness check?
One with numeric criteria and a closure rule, such as all of the next 10 PBS batches within 7.4 ± 0.1 and no related deviations. State who reviews the data and when.
Do I need to cite Deming, Crosby and Juran directly?
Yes. Cite the original books or the Juran handbook rather than websites, and use them to explain why you reject a person-based root cause and favour a system explanation.
References
Calnan, N., O’Donnell, K. and Greene, A. (2013) ‘Enabling ICH Q10 implementation – Part 1. Striving for excellence by embracing ICH Q8 and ICH Q9’, PDA Journal of Pharmaceutical Science and Technology, 67(6), pp. 581–600. doi:10.5731/pdajpst.2013.00940.
Crosby, P.B. (1979) Quality is free: the art of making quality certain. New York: McGraw-Hill.
Deming, W.E. (2000) Out of the crisis. Cambridge, MA: MIT Press.
European Commission (2013) EudraLex Volume 4 – EU guidelines for good manufacturing practice, Chapter 1: Pharmaceutical quality system. Available at: https://health.ec.europa.eu/system/files/2016-11/vol4-chap1_2013-01_en_0.pdf (Accessed: 21 October 2026).
European Medicines Agency (EMA) (2015) ICH guideline Q10 on pharmaceutical quality system, EMA/CHMP/ICH/214732/2007. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-guideline-q10-pharmaceutical-quality-system-step-5_en.pdf (Accessed: 21 October 2026).
Food and Drug Administration (2022) Investigating out-of-specification (OOS) test results for pharmaceutical production: guidance for industry (Revision 1). Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigating-out-specification-test-results-pharmaceutical-production (Accessed: 21 October 2026).
Juran, J.M. and De Feo, J.A. (eds.) (2017) Juran’s quality handbook: the complete guide to performance excellence. 7th edn. New York: McGraw-Hill.
VanDuyse, S.A., Fulford, M.J. and Bartlett, M.G. (2021) ‘ICH Q10 pharmaceutical quality system guidance: understanding its impact on pharmaceutical quality’, The AAPS Journal, 23(6), article 117. doi:10.1208/s12248-021-00657-y.
